Family Farmace Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-12-2024
- Paid Up Capital ₹ 2.00 M
as on 08-12-2024
- Company Age 26 Year, 24 Days
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 6.95 M
as on 08-12-2024
- Revenue -0.91%
(FY 2019)
- Profit 893.13%
(FY 2019)
- Ebitda -7.40%
(FY 2019)
- Net Worth 5.64%
(FY 2019)
- Total Assets -10.99%
(FY 2019)
About Family Farmace
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹6.95 M.
Mahesh Rakheja and Sunita Rakheja serve as directors at the Company.
- CIN/LLPIN
U51397DL1998PTC097240
- Company No.
097240
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 1998
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Family Farmace Private Limited offer?
Family Farmace Private Limited offers a wide range of products and services, including Face Mask & Medical PPE Kits, Medical & Industrial Mask.
Who are the key members and board of directors at Family Farmace?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mahesh Rakheja | Director | 16-Aug-2001 | Current |
Sunita Rakheja | Director | 27-Nov-1998 | Current |
Financial Performance and Corporate Structure Insights of Family Farmace.
Family Farmace Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 0.91% decrease. The company also saw a substantial improvement in profitability, with a 893.13% increase in profit. The company's net worth moved up by a moderate rise of 5.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Family Farmace?
In 2019, Family Farmace had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Family Wellness Private LimitedActive 12 years 10 months
Mahesh Rakheja and Sunita Rakheja are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 07 Aug 2010 | ₹5.50 M | Open |
State Bank Of India Creation Date: 04 Dec 2001 | ₹1.00 M | Open |
State Bank Of India Creation Date: 19 Mar 1999 | ₹0.45 M | Open |
How Many Employees Work at Family Farmace?
Unlock and access historical data on people associated with Family Farmace, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Family Farmace, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Family Farmace's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.